C. Robert Horsburgh Jr, MD
Professor
Boston University School of Public Health
Global Health

MD, Case Western Reserve University
MS, Yale University
AB, Princeton University



Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Professor
Boston University School of Public Health
Epidemiology


Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

Professor
Boston University School of Public Health
Biostatistics


Boston Medical Center




DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
08/21/2020 - 05/31/2025 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
The Regents of the University of California, San Francisco NIH NIAID
5U01AI152980-03

Optimal targeting for individual and population-level TB prevention
12/05/2019 - 11/30/2024 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID
5R01AI146555-05

RePORT India Phase II
11/20/2019 - 11/19/2024 (Subcontract PI)
CRDF Global USDA Agricult ResSvc


Tuberculosis Trial Consortium
10/01/2019 - 09/30/2024 (Subcontract PI)
Veterans Affairs Medical Center of Washington DC HHS CDC
20FED2000031PSE

Prevention Policy Modeling Lab
09/30/2019 - 09/29/2024 (Subcontract PI)
Stanford University HHS CDC
5NU38PS004651

Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
08/01/2019 - 07/31/2024 (Subcontract PI)
Boston Medical Center Corporation NIH NIAID
5R01AI147316-05

Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
08/15/2017 - 07/31/2024 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
NIH/National Institute of Allergy & Infectious Diseases
5R01AI134430-05

Dartmouth-Boston University HIV-TB Research Training for the Infectious Disease Institute at Muhimbili University of Health and Allied Sciences
06/01/2018 - 06/30/2024 (Subcontract PI)
Dartmouth College NIH FIC
5D43TW009573-10

Providence/Boston Center for AIDS Research (CFAR): Core Support (Cores A, B, E, G, K, SWG)
07/01/2018 - 06/30/2023 (Subcontract PI)
The Miriam Hospital NIH NIAID
5P30AI042853-24

Biomarkers and mechanisms of Paucibacillary and Latent Tuberculosis
11/01/2018 - 07/31/2022 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
Rutgers, The State University of New Jersey NIH NIAID
5U19AI111276-08

Showing 10 of 36 results. Show All Results

MDR-TB and HIV at RePORT Sites in India (Supplement)
08/24/2017 - 08/23/2018 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core K Clinical Sciences Core
07/01/2016 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

BU Clinical HIV/AIDS Research Training Program
08/02/2010 - 07/31/2016 (PI)
NIH-NIAID
5T32AI052074-10

Boston Community Partnership Against HIV
09/30/2002 - 09/29/2005 (PI)
DHHS-Office Minority Hlth

History Of Hepatitis C Infecti
09/30/1999 - 06/30/2005 (PI)
NIH-NIDDK
5 R01 DK56410-05 & Supplement


Title


Yr Title Project-Sub Proj Pubs
2023 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-04
2022 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-03
2021 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-02
2021 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-05
2020 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 1U01AI152980-01
2020 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-04
2020 Clinical Core 5U19AI111276-08-7772 34
2019 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-03
2019 Clinical Core 5U19AI111276-07-7772 34
2018 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-02
Showing 10 of 56 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Li Y, Regan M, Swartwood NA, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data. Ann Intern Med. 2024 Apr; 177(4):418-427. PMID: 38560914
     
  2. Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR, Murray M, Lange C. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024 Mar 24; 10(1):22. PMID: 38523140
     
  3. Yamkovoy K, Self JL, Jenkins HE, Horsburgh CR, White LF. Patterns of TB transmission in the United States, 2011-2017. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):154-156.View Related Profiles. PMID: 38454181; PMCID: PMC11044277; DOI: 10.5588/ijtld.23.0422;
     
  4. Leavitt SV, Rodriguez CA, Bouton TC, Horsburgh CR, Abel Zur Wiesch P, Nichols BE, White LF, Jenkins HE. Outcomes for people with TB by disease severity at presentation. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):142-147.View Related Profiles. PMID: 38454178; PMCID: PMC11075045; DOI: 10.5588/ijtld.23.0254;
     
  5. Sinha P, Dauphinais M, Carwile ME, Horsburgh CR, Menzies NA. In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study. medRxiv. 2024 Jan 01.View Related Profiles. PMID: 38260435; PMCID: PMC10802630; DOI: 10.1101/2023.12.30.23300673;
     
  6. Regan M, Li Y, Swartwood NA, Barham T, Asay GRB, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance data. Lancet Public Health. 2024 Jan; 9(1):e47-e56. PMID: 38176842
     
  7. Rodriguez CA, Horsburgh CR, Jenkins HE, White LF. Reply to 'Estimating TB survival - mind the immortal-time gap'. Int J Tuberc Lung Dis. 2024 Jan 01; 28(1):66-67.View Related Profiles. PMID: 38178287
     
  8. du Cros P, Greig J, Alffenaar JC, Cross GB, Cousins C, Berry C, Khan U, Phillips PPJ, Velásquez GE, Furin J, Spigelman M, Denholm JT, Thi SS, Tiberi S, Huang GKL, Marks GB, Turkova A, Guglielmetti L, Chew KL, Nguyen HT, Ong CWM, Brigden G, Singh KP, Motta I, Lange C, Seddon JA, Nyang'wa BT, Maug AKJ, Gler MT, Dooley KE, Quelapio M, Tsogt B, Menzies D, Cox V, Upton CM, Skrahina A, McKenna L, Horsburgh CR, Dheda K, Marais BJ. Standards for clinical trials for treating TB. Int J Tuberc Lung Dis. 2023 Dec 01; 27(12):885-898. PMID: 38042969; PMCID: PMC10719894; DOI: 10.5588/ijtld.23.0341;
     
  9. Hu Z, Liu K, Zhou M, Jiang X, Feng Y, Yu Z, Li Y, Chen S, Wu Q, Wang W, Horsburgh CR, Zhang Y, Zhou L, Chen B, Hu C, Martinez L. Mass Tuberculosis Screening Among the Elderly: A Population-Based Study in a Well-Confined, Rural County in Eastern China. Clin Infect Dis. 2023 Nov 17; 77(10):1468-1475.View Related Profiles. PMID: 37506258; PMCID: PMC10654880; DOI: 10.1093/cid/ciad438;
     
  10. Swartwood NA, Testa C, Cohen T, Marks SM, Hill AN, Beeler Asay G, Cochran J, Cranston K, Randall LM, Tibbs A, Horsburgh CR, Salomon JA, Menzies NA. Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Med. 2023 Aug 30; 21(1):331. PMID: 37649031; PMCID: PMC10469407; DOI: 10.1186/s12916-023-02785-y;
     
Showing 10 of 353 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 336 publications over 43 distinct years, with a maximum of 21 publications in 2020

YearPublications
19811
19833
19844
19855
19865
19875
19884
198914
19904
19916
19928
19939
19947
19958
19965
19978
19985
19997
20008
20012
20025
20034
20045
20053
20069
20073
20087
20093
201011
201114
20128
201310
20149
201512
201611
20179
201819
201915
202021
202118
20224
202311
20247


Bump or spike? COVID in wastewater has experts unsurprised but wary

WBUR 12/6/2022

What to know about COVID's upswing in Massachusetts

WBUR 5/13/2022

Experts predict a COVID ‘swell’ — rather than a ‘wave’ — as cases tick upward in Mass.

WBUR 4/14/2022

What health experts expect from the next COVID phase in Massachusetts

WBUR 2/18/2022

With pediatric COVID vaccines a reality, experts reexamine whether ‘herd immunity’ is possible

WBUR 11/4/2021

Tuberculosis, Like Covid, Spreads by Breathing, Scientists Report

The New York Times 10/19/2021

COVID-19 hospitalizations have dropped over the week in Maine

WABI 10/8/2021

Baystate Business: Gaming, Dining, Covid (Radio)

Bloomberg 8/9/2021

Rate of breakthrough cases in Cape Cod cluster raises questions at CDC

The Boston Globe 7/30/2021

Provincetown COVID-19 cases climb to 882

The Boston Globe 7/29/2021

Provincetown leaders impose stricter mask rules amid COVID-19 case surge

The Boston Globe 7/25/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates (

The Boston Globe 5/3/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates

The Boston Globe 5/2/2021

Biden, public health officials face crossroads on COVID-19

The Boston Globe 3/14/2021

Texas Restaurants, Bars to Reopen at Full Capacity; Workers Not Yet Eligible for Vaccine

Food & Wine 3/3/2021

Live Blog: American life begins to return to normal, even as some fear it’s too soon.

The New York Times 3/2/2021

Texas Drops Its Virus Restrictions as a Wave of Reopenings Takes Hold

The New York Times 3/2/2021

Stadium supper, dance zones, rethinking oysters: News from around our 50 states

USA Today 3/2/2021

Moving forward in Massachusetts reopening 'careless, reckless,' Somerville mayor says

WCVB 3/1/2021

Baker pledges continued focus on vaccine equity, stands by moving forward with Mass. reopening

The Boston Globe 3/1/2021

Baker stands by loosening reopening restrictions, expects Johnson & Johnson vaccine supply later this month

The Boston Globe 3/1/2021

Baystate Business: Re-Opening Controversy (Radio)

Bloomberg 3/1/2021

‘Charlie, you’re making a big mistake’: Experts criticize state’s Monday reopening

The Boston Globe 2/28/2021

Baystate Business: Legends of Local TV (Radio)

Bloomberg 12/3/2020

COVID-19 impact from Thanksgiving travel and gatherings could be ‘precursor’ for upcoming holidays

The Boston Globe 11/29/2020

Troubling signs emerge that COVID-19 is tightening its hold on the state

The Boston Globe 11/1/2020

State reports more than 1,100 new coronavirus cases, prompting calls for a new state plan

The Boston Globe 10/24/2020

Baystate Business: Covid on the Rise (Radio)

Bloomberg 10/5/2020

Testing, schools, and a vaccine: What these experts are watching this fall amid COVID-19 in Mass

The Boston Globe 8/16/2020

Boston, Phase 3 reopening is all about safety, business owners say

The Boston Globe 7/12/2020

Scientists warn May 18 ‘still feels too early’ to begin reopening Mass.

The Boston Globe 5/12/2020

4 Bright Spots Amid the Gloom of Coronavirus

The New York Times 3/27/2020

Mass. Needs More Coronavirus Testing Now, Public Health Experts Say

WBUR 3/17/2020

Mass. increases coronavirus testing, ‘but it’s not nearly enough,’ some say

The Boston Globe 3/15/2020

2015 International Union Against Tuberculosis and Lung Disease, North American Region: Lifetime Achievement Award
2011 Boston University School of Public Health: Faculty Career Award in Research and Scholarship
2011 CDC: Excellence in Public Health Impact Award
2004 BUSPH: Teaching Award
1997 Emory University: Teaching Award
1989 US PHS Commendation Medal
1977 Lubrizol Award for Patient Care
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map


Horsburgh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department